Skip to main content

Mechanochemical Ablation of Superficial Veins

  • Chapter
  • First Online:
Current Management of Venous Diseases

Abstract

Endovenous thermal ablation of saphenous vein is currently the standard, minimally invasive treatment of choice for venous insufficiency. The procedure has become increasingly popular as it compares favorably with traditional surgical ligation and stripping with regard to complications and recovery. The recent introduction of nonthermal ablative techniques such as mechanochemical ablation has shown equivalent clinical efficacy with less discomfort by avoiding the use of tumescent anesthesia. This chapter gives an overview of the technique and outcomes of mechanochemical ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Gloviczki P, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American venous forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S.

    Article  PubMed  Google Scholar 

  2. van Eekeren RR, et al. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg. 2013;57(2):445–50.

    Article  PubMed  Google Scholar 

  3. Brittenden J, et al. A randomized trial comparing treatments for varicose veins. N Engl J Med. 2014;371(13):1218–27.

    Article  CAS  PubMed  Google Scholar 

  4. Witte ME, et al. Mechanochemical endovenous occlusion of varicose veins using the ClariVein(R) device. Surg Technol Int. 2015;26:219–25.

    PubMed  Google Scholar 

  5. Gibson KD, Ferris BL, Pepper D. Endovenous laser treatment of varicose veins. Surg Clin North Am. 2007;87(5):1253–65, xii.

    Article  PubMed  Google Scholar 

  6. Anwar MA, et al. Complications of radiofrequency ablation of varicose veins. Phlebology. 2012;27(Suppl 1):34–9.

    Article  PubMed  Google Scholar 

  7. Dexter D, et al. Complications of endovenous lasers. Phlebology. 2012;27(Suppl 1):40–5.

    Article  PubMed  Google Scholar 

  8. Boersma D, et al. Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the ClariVein OC device in an animal model. Eur J Vasc Endovasc Surg. 2017;53(2):290–8.

    Article  CAS  PubMed  Google Scholar 

  9. Whiteley MS, et al. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord. 2017;5(3):370–7.

    Article  PubMed  Google Scholar 

  10. van Eekeren RR, et al. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. J Endovasc Ther. 2011;18(3):328–34.

    Article  PubMed  Google Scholar 

  11. Elias S, Lam YL, Wittens CH. Mechanochemical ablation: status and results. Phlebology. 2013;28(Suppl 1):10–4.

    Article  PubMed  Google Scholar 

  12. Mueller RL, Raines JK. ClariVein mechanochemical ablation: background and procedural details. Vasc Endovasc Surg. 2013;47(3):195–206.

    Article  Google Scholar 

  13. Tang TY, Kam JW, Gaunt ME. ClariVein® – early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins. Phlebology. 2017;32(1):6–12.

    Article  CAS  PubMed  Google Scholar 

  14. Deijen CL, et al. Clarivein mechanochemical ablation of the great and small saphenous vein: early treatment outcomes of two hospitals. Phlebology. 2016;31(3):192–7.

    Article  PubMed  Google Scholar 

  15. Boersma D, et al. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the ClariVein® device: one-year results of a prospective series. Eur J Vasc Endovasc Surg. 2013;45(3):299–303.

    Article  CAS  PubMed  Google Scholar 

  16. Darke SG, Baker SJ. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. Br J Surg. 2006;93(8):969–74.

    Article  CAS  PubMed  Google Scholar 

  17. Rasmussen LH, et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98(8):1079–87.

    Article  CAS  PubMed  Google Scholar 

  18. Gillet JL, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology. 2009;24(3):131–8.

    Article  PubMed  Google Scholar 

  19. Elias S, Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology. 2012;27(2):67–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bishawi M, et al. Mechanochemical ablation in patients with chronic venous disease: a prospective multicenter report. Phlebology. 2014;29(6):397–400.

    Article  CAS  PubMed  Google Scholar 

  21. van Eekeren RR, et al. Mechanochemical endovenous ablation versus RADiOfrequeNcy ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial. Trials. 2014;15:121.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kim PS, et al. Mechanochemical ablation for symptomatic great saphenous vein reflux: a two-year follow-up. Phlebology. 2017;32(1):43–8.

    Article  PubMed  Google Scholar 

  23. Bootun R, et al. Intra-procedural pain score in a randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: the multicentre Venefit versus ClariVein® for varicose veins trial. Phlebology. 2016;31(1):61–5.

    Article  CAS  PubMed  Google Scholar 

  24. Vun SV, et al. Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®. Phlebology. 2015;30(10):688–92.

    Article  CAS  PubMed  Google Scholar 

  25. Lam YL, Toonder IM, Wittens CH. Clarivein® mechano-chemical ablation an interim analysis of a randomized controlled trial dose-finding study. Phlebology. 2016;31(3):170–6.

    Article  CAS  PubMed  Google Scholar 

  26. Leung CC, et al. Endovenous laser ablation versus mechanochemical ablation with ClariVein® in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trial. Trials. 2016;17(1):421.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Leung C, et al. IF08. A randomized controlled trial comparing endovenous laser ablation vs mechanochemical ablation in the treatment of superficial venous incompetence: the LAMA trial. J Vasc Surg. 2017;65(6):35S.

    Article  Google Scholar 

  28. Boersma D, et al. Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial. Trials. 2014;15:421.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lane T, et al. A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins – final results of the Venefit versus Clarivein for varicose veins trial. Phlebology. 2017;32(2):89–98.

    Article  PubMed  Google Scholar 

  30. Uncu H. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Phlebology. 2010;25(1):44–9.

    Article  CAS  PubMed  Google Scholar 

  31. Hirsch T. Varicose vein therapy and nerve lesions. Vasa. 2017;46(2):96–100.

    Article  PubMed  Google Scholar 

  32. Gibson KD, et al. Endovenous laser treatment of the small [corrected] saphenous vein: efficacy and complications. J Vasc Surg. 2007;45(4):795–801. discussion 801-3

    Article  PubMed  Google Scholar 

  33. Park SW, et al. Endovenous laser ablation of the incompetent small saphenous vein with a 980-nm diode laser: our experience with 3 years follow-up. Eur J Vasc Endovasc Surg. 2008;36(6):738–42.

    Article  CAS  PubMed  Google Scholar 

  34. Theivacumar NS, et al. Initial experience in endovenous laser ablation (EVLA) of varicose veins due to small saphenous vein reflux. Eur J Vasc Endovasc Surg. 2007;33(5):614–8.

    Article  CAS  PubMed  Google Scholar 

  35. Bootun R, Lane TR, Davies AH. The advent of non-thermal, non-tumescent techniques for treatment of varicose veins. Phlebology. 2016;31(1):5–14.

    Article  PubMed  Google Scholar 

  36. Witte ME, et al. Mechanochemical endovenous ablation of saphenous veins using the ClariVein: a systematic review. Phlebology. 2017:268355517702068.

    Google Scholar 

  37. Lane TR, et al. Retrograde inversion stripping as a complication of the ClariVein mechanochemical venous ablation procedure. Ann R Coll Surg Engl. 2015;97(2):e18–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Todd KL 3rd, Wright DI. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Phlebology. 2014;29(9):608–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cassius Iyad N. Ochoa Chaar MD, MS, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aurshina, A., Ochoa Chaar, C.I.N. (2018). Mechanochemical Ablation of Superficial Veins. In: Chaar, C. (eds) Current Management of Venous Diseases . Springer, Cham. https://doi.org/10.1007/978-3-319-65226-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65226-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65225-2

  • Online ISBN: 978-3-319-65226-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics